Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 3NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 13Genitourinary 8Sarcoma 2Dermatologic 2Tumor-Agnostic 1Thoracic 1Gynecologic 1CNS 1

Conditions

Sarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Desmoid Tumors 1

Interventions

Radiotherapy 35Doxorubicin 30Ifosfamide 29Cyclophosphamide 24Vincristine 23Filgrastim 23Etoposide 20Temozolomide 14Granulocyte Colony-Stimulating Factor 14Dactinomycin 11Cisplatin 11Trabectedin 10Methotrexate 10Gene Expression Profiling 10Radiation 9Imatinib Mesylate 9Surgical Procedures, Operative 8Polymerase Chain Reaction 8Irinotecan 8Specimen Handling 7Paclitaxel 7Chemotherapy, Adjuvant 7Mesna 6Immunohistochemistry 6Gemcitabine 6Carmustine 6Biopsy 6sargramostim 5pegfilgrastim 5etoposide phosphate 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Vinblastine × Sarcoma × Clear all
NCT00061893 2019-02-15

Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors

Children's Oncology Group

Phase 2 Completed
38 enrolled 10 charts
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

NCT00003019 2014-07-25

Vinblastine and Methotrexate in Treating Children With Desmoid Tumors

Children's Oncology Group

Phase 2 Completed
28 enrolled
Sarcoma

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡